Department of Breast and Thyroid Surgery, The Affiliated Huaian Hospital of Xuzhou Medical University, Huaian 223000, China.
Department of Breast and Thyroid Surgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.
Biomed Res Int. 2020 Apr 29;2020:7907269. doi: 10.1155/2020/7907269. eCollection 2020.
Triple-negative breast cancer (TNBC) is the most aggressive subtypes of breast cancer, which has few effective targeted therapies. Various sources of evidence confirm that microRNAs (miRNAs) contribute to the progression and metastasis of human breast cancer. However, the molecular mechanisms underlying the changes in miRNAs expression and the regulation of miRNAs functions have not been well clarified. In this study, we found that the expression of miR-30b-5p was upregulated in breast cancer tissues and breast cancer cell lines, compared to paracancer tissues and normal breast cell lines. Moreover, induced overexpression of miR-30b-5p promoted the MDA-MB-231 and HCC 1937 cell growth, migration, and invasion and reduced the cellular apoptosis. Further studies confirmed that miR-30b-5p could directly target ASPP2 and then activate the AKT signaling pathway. Our results suggested that miR-30b-5p could act as a tumor promoter in TNBC. The newly identified miR-30b-5p/ASPP2/AKT axis represents a novel therapeutic strategy for treating TNBC.
三阴性乳腺癌(TNBC)是乳腺癌中侵袭性最强的亚型,其有效的靶向治疗方法较少。各种来源的证据证实,microRNAs(miRNAs)参与了人类乳腺癌的进展和转移。然而,miRNAs 表达变化的分子机制以及 miRNAs 功能的调节尚未得到很好的阐明。在这项研究中,我们发现 miR-30b-5p 的表达在乳腺癌组织和乳腺癌细胞系中上调,与癌旁组织和正常乳腺细胞系相比。此外,诱导过表达 miR-30b-5p 促进了 MDA-MB-231 和 HCC 1937 细胞的生长、迁移和侵袭,并降低了细胞凋亡。进一步的研究证实,miR-30b-5p 可以直接靶向 ASPP2 并激活 AKT 信号通路。我们的研究结果表明,miR-30b-5p 可以作为 TNBC 的肿瘤促进因子。新发现的 miR-30b-5p/ASPP2/AKT 轴为治疗 TNBC 提供了一种新的治疗策略。